scholarly journals Stem Cells for Modeling Human Disease

Author(s):  
F. Martín ◽  
A. Sánchez-Gilabert ◽  
M. Tristán-Manzano ◽  
K. Benabdellah
Keyword(s):  
2021 ◽  
Author(s):  
William C Skarnes ◽  
Gang Ning ◽  
Sofia Giansiracusa ◽  
Alexander S Cruz ◽  
Cornelis Blauwendraat ◽  
...  

Modeling human disease in human stem cells requires precise, scarless editing of single nucleotide variants (SNV) on one or both chromosomes. Here we describe improved conditions for Cas9 RNP editing of SNVs that yield high rates of biallelic homology-directed repair. To recover both heterozygous and homozygous SNV clones, catalytically inactive dCas9 was added to moderate high activity Cas9 RNPs. dCas9 can also block re-cutting and damage to SNV alleles engineered with non-overlapping guide RNAs.


2022 ◽  
Vol 11 (1) ◽  
Author(s):  
Xiaoxiang Lu ◽  
Jiajie Yang ◽  
Yangfei Xiang

AbstractStudying the etiology of human neurodevelopmental diseases has long been a challenging task due to the brain’s complexity and its limited accessibility. Human pluripotent stem cells (hPSCs)-derived brain organoids are capable of recapitulating various features and functionalities of the human brain, allowing the investigation of intricate pathogenesis of developmental abnormalities. Over the past years, brain organoids have facilitated identifying disease-associated phenotypes and underlying mechanisms for human neurodevelopmental diseases. Integrating with more cutting-edge technologies, particularly gene editing, brain organoids further empower human disease modeling. Here, we review the latest progress in modeling human neurodevelopmental disorders with brain organoids.


2010 ◽  
Vol 21 (11) ◽  
pp. 1513-1526 ◽  
Author(s):  
Conrad P. Hodgkinson ◽  
José A. Gomez ◽  
Maria Mirotsou ◽  
Victor J. Dzau

2013 ◽  
Vol 13 (2) ◽  
pp. 99-110 ◽  
Author(s):  
Richard Siller ◽  
Sebastian Greenhough ◽  
In-Hyun Park ◽  
Gareth J. Sullivan

Sign in / Sign up

Export Citation Format

Share Document